Shilpa Medicare Overview
- Year Founded
-
1987
- Status
-
Public
- Employees
-
3,074
- Stock Symbol
-
530549
- Investments
-
15
- Share Price
-
$9.96
- (As of Monday Closing)
Shilpa Medicare General Information
Description
Shilpa Medicare Ltd is a specialty and generic drug manufacturer. The company deals in high-quality Active Pharmaceutical Ingredients (APIs), Intermediates, Formulations, New Drug Delivery Systems, Peptides, Biotech products, and Specialty Chemicals etc. Its portfolio comprises various oncology and non-oncology-related APIs such as anastrozole, acebrophylline, busulphan, decitabine, etc, and finished dosage formulations such as apremilast tablets, clofarabine injection, docetaxel injection, etc., in various therapy areas. Its reporting segments are: Pharmaceutical product and services, which derive maximum revenue, Power sales, and Others. Geographically, the company generates maximum revenue from India, followed by Europe, the United States of America, and the Rest of the world.
Contact Information
Website
www.vbshilpa.comCorporate Office
- Suite 12-6-214/A1
- Hyderabad Road
- Raichur, Karnataka 584135
- India
Corporate Office
- Suite 12-6-214/A1
- Hyderabad Road
- Raichur, Karnataka 584135
- India
Shilpa Medicare Stock Performance
As of 16-Nov-2026, Shilpa Medicare’s stock price is $9.96. Its current market cap is $1.95B with 196M shares.
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $9.96 | $10.56 | $2.83 - $11.42 | $1.95B | 196M | 63.8K | $0.18 |
Shilpa Medicare Financials Summary
As of 30-Sep-2026, Shilpa Medicare has a trailing 12-month revenue of $199M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2026 31-Mar-2026 | FY 2025 31-Mar-2025 | FY 2024 31-Mar-2024 |
|---|---|---|---|---|
| EV | 2,193,785 | 776,515 | 808,551 | 579,370 |
| Revenue | 198,623 | 174,052 | 151,943 | 139,014 |
| EBITDA | 62,494 | 52,166 | 35,814 | 29,539 |
| Net Income | 35,854 | 27,537 | 9,259 | 3,850 |
| Total Assets | 430,765 | 392,741 | 387,036 | 370,921 |
| Total Debt | 69,339 | 69,936 | 68,712 | 112,405 |
Shilpa Medicare Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Shilpa Medicare Comparisons
Industry
Financing
Details
Shilpa Medicare Competitors (33)
One of Shilpa Medicare’s 33 competitors is Aarti Drugs, a Corporation company based in Mumbai, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Aarti Drugs | Corporation | Mumbai, India | ||||
| Neuland Laboratories | Corporation | Hyderabad, India | ||||
| Marksans Pharma | Corporation | Mumbai, India | ||||
| Gland Pharma | Formerly PE-Backed | Hyderabad, India | ||||
| Lonza Group | Corporation | Basel, Switzerland |
Shilpa Medicare Patents
Shilpa Medicare Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260272886-A1 | Ondansetron extendable release injectable suspension and methods of use | Pending | 11-Mar-2025 | ||
| WO-2026190541-A1 | Ondansetron extendable release injectable suspension and methods of use | Pending | 11-Mar-2025 | ||
| US-20250114342-A1 | Apixaban oral liquid dosage forms | Pending | 04-Oct-2023 | ||
| WO-2024105521-A1 | Stable peptide pharmaceutical composition | Inactive | 17-Nov-2022 | ||
| AU-2023313512-A1 | Pharmaceutical compositions of nor-udca | Pending | 25-Jul-2022 | A61K9/2054 |
Shilpa Medicare Signals
Shilpa Medicare Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Shilpa Medicare Investments & Acquisitions (15)
Shilpa Medicare’s most recent deal was a Corporate with Gate2Brain for . The deal was made on 03-Jun-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Gate2Brain | 03-Jun-2026 | Corporate | Drug Discovery | ||
| Alveolus Bio | 04-Aug-2025 | Later Stage VC | Drug Discovery | ||
| Pilnova Pharma | 02-Nov-2023 | Merger/Acquisition | Media and Information Services (B2B) | ||
| FTF Pharma | 02-Nov-2020 | Merger/Acquisition | Drug Discovery | ||
| Auxilla Pharmaceuticals and Research | 16-Jun-2020 | Corporate | Drug Delivery |
Shilpa Medicare ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
33.27 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,592
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Pharmaceuticals
Subindustry
of 354
Rank
Percentile
Shilpa Medicare Exits (2)
Shilpa Medicare’s most recent exit was on 23-Apr-2013 from MAIA Pharmaceuticals. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| MAIA Pharmaceuticals | 23-Apr-2013 | Completed |
|
||
| Loba biotech | 31-Mar-2008 | Buyout/LBO | Completed |
|
Shilpa Medicare Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Shilpa Pharma Lifesciences | Raichur, India | 2022 | |
| FTF Pharma | Ahmedabad, India | 2012 |
Shilpa Medicare FAQs
-
When was Shilpa Medicare founded?
Shilpa Medicare was founded in 1987.
-
Where is Shilpa Medicare headquartered?
Shilpa Medicare is headquartered in Raichur, India.
-
What is the size of Shilpa Medicare?
Shilpa Medicare has 3,074 total employees.
-
What industry is Shilpa Medicare in?
Shilpa Medicare’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Shilpa Medicare a private or public company?
Shilpa Medicare is a Public company.
-
What is Shilpa Medicare’s stock symbol?
The ticker symbol for Shilpa Medicare is 530549.
-
What is the current stock price of Shilpa Medicare?
As of 16-Nov-2026 the stock price of Shilpa Medicare is $9.96.
-
What is the current market cap of Shilpa Medicare?
The current market capitalization of Shilpa Medicare is $1.95B.
-
What is Shilpa Medicare’s current revenue?
The trailing twelve month revenue for Shilpa Medicare is $199M.
-
Who are Shilpa Medicare’s competitors?
Aarti Drugs, Neuland Laboratories, Marksans Pharma, Gland Pharma, and Lonza Group are some of the 33 competitors of Shilpa Medicare.
-
What is Shilpa Medicare’s annual earnings per share (EPS)?
Shilpa Medicare’s EPS for 12 months was $0.18.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process